Asia-focused private equity firm PAG, along with consortium partners CX Partners and Samara Capital, has reached an agreement to acquire a controlling stake in Chennai-based drug manufacturer Anjan Drug Pvt. Ltd, it announced on Monday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
